Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 58 min ago
PreprintCC BY-NCmedRxiv

The Para-ISS Dural Space Enhancement Sign: A Novel MRI Finding Independently Associated With Intracranial Atherosclerotic Burden

  1. 1Department of Radiology, Shantou Central Hospital, Shantou 515031, China; Clinical Research Center, Shantou Central Hospital, Shantou 515031, China

Abstract

Background: No dural enhancement sign centered on the inferior sagittal sinus (ISS) has been characterized. We observed a frequent, previously undescribed finding - para-ISS dural space enhancement (PISE) - at the free inferior margin of the falx cerebri. Objective: To define PISE, determine its detection rate in a large cross-sectional cohort, and characterize its correlates, in particular whether the pattern of association is compatible with an atherosclerosis-related dural mechanism. Methods: Consecutive contrast-enhanced intracranial vessel-wall MRI (VWI) examinations (May 2015-December 2025) were reviewed; 835 of 875 examinations were evaluable, corresponding to 811 patients. The first outcome-evaluable examination for each patient was used for all primary analyses. PISE was defined as dural enhancement strictly at the falx free margin adjacent to the ISS, exceeding the ISS vascular lumen. Forty-seven demographic, clinical-history, and imaging variables were tested univariately with Benjamini-Hochberg false discovery rate (FDR) correction; multivariable logistic regression with patient-grouped 5-fold cross-validation was triangulated with LASSO and random forest. Dose-response across plaque grades was assessed with the Cochran-Armitage trend test, and circulation-specific associations were compared in models adjusted for age and sex (inter-reader Cohen's kappa = 0.93). Results: PISE was detected in 609/811 patients (75.1%); detection rose from 50.0% (<40 years) to 81.7% (>70 years; trend p = 5.6 x 10^-6). The strongest univariate correlate was vulnerable intracranial plaque (OR=8.29, 95% CI 5.54-12.40). Detection increased across plaque grades 0/1/2 (38.7% -> 77.2% -> 90.3%; Z=11.09). Anterior-circulation plaque showed a stronger association than posterior-circulation plaque (OR=4.42 vs 2.76). Vulnerable plaque (OR=2.37), plaque grade (OR=2.84 per grade), age (OR=1.38 per SD), and inpatient status (OR=3.18) remained independently associated (patient-grouped cross-validated AUC=0.755). Moyamoya disease was inversely associated (OR=0.25). Findings were consistent across imputation and all-examination sensitivity analyses. Conclusions: PISE is a frequently detected novel dural enhancement sign whose independent, graded, anatomically concordant association with intracranial atherosclerotic burden supports an atherosclerosis-related dural mechanism and warrants prospective validation.

Related

  1. Stent retriever angioplasty with the Tigertriever as a bailout strategy for intracranial atherosclerotic disease–related large-vessel occlusion: illustrative cases
    Yukinori Terada, Takeshi Kawauchi, Kazuhiro Kojima +2
    Journal of neurosurgery. Case lessonsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Diagnostic and prognostic value of on-site CT-derived fractional flow reserve in intracranial atherosclerotic stenosis
    Xinran Wang, Xuan Zeng, Jian Guo +6
    Journal of Cerebral Blood Flow & MetabolismPeer-reviewedLicence not statedFull textCardiovascular medicinePMC
  3. The clinical application of a low-profile stent for symptomatic intracranial atherosclerotic stenosis in the middle cerebral artery: a retrospective study of the Atlas stent
    Wenyan Xu, Xu Guan, Fangfang Guo +13
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  4. Hemodynamic biomarkers in symptomatic intracranial atherosclerotic stenosis: evidence boundaries and research pathways from prognostic stratification to treatment-effect prediction
    Ruying Hu, Zizhao Zhang, Zipeng Wang +3
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMCEurope PMCPMC
  5. Association of intracranial plaque characteristics and cerebral small vessel disease burden with acute ischemic stroke in patients with intracranial atherosclerotic disease.
    Jiali Miao, Zhimeng Cui, Yixin Chen +4
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
BibTeX
@misc{zeng2026paraiss,
  title = {{The Para-ISS Dural Space Enhancement Sign: A Novel MRI Finding Independently Associated With Intracranial Atherosclerotic Burden}},
  author = {S. Zeng and D. Lin and K. Tang and F. Zeng and X. Zheng and M. Li and J. Lin and B. Huang and S. Zhan and S. Chen and Z. Dai},
  howpublished = {medRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.04.26367240},
  url = {https://www.medrxiv.org/content/10.64898/2026.11.04.26367240v1},
  note = {CC BY-NC},
}
RIS
TY  - UNPB
TI  - The Para-ISS Dural Space Enhancement Sign: A Novel MRI Finding Independently Associated With Intracranial Atherosclerotic Burden
AU  - S. Zeng
AU  - D. Lin
AU  - K. Tang
AU  - F. Zeng
AU  - X. Zheng
AU  - M. Li
AU  - J. Lin
AU  - B. Huang
AU  - S. Zhan
AU  - S. Chen
AU  - Z. Dai
PY  - 2026
DA  - 2026/11/04
PB  - medRxiv
DO  - 10.64898/2026.11.04.26367240
UR  - https://www.medrxiv.org/content/10.64898/2026.11.04.26367240v1
AB  - Background: No dural enhancement sign centered on the inferior sagittal sinus (ISS) has been characterized. We observed a frequent, previously undescribed finding - para-ISS dural space enhancement (PISE) - at the free inferior margin of the falx cerebri. Objective: To define PISE, determine its detection rate in a large cross-sectional cohort, and characterize its correlates, in particular whether the pattern of association is compatible with an atherosclerosis-related dural mechanism. Methods: Consecutive contrast-enhanced intracranial vessel-wall MRI (VWI) examinations (May 2015-December 2025) were reviewed; 835 of 875 examinations were evaluable, corresponding to 811 patients. The first outcome-evaluable examination for each patient was used for all primary analyses. PISE was defined as dural enhancement strictly at the falx free margin adjacent to the ISS, exceeding the ISS vascular lumen. Forty-seven demographic, clinical-history, and imaging variables were tested univariately with Benjamini-Hochberg false discovery rate (FDR) correction; multivariable logistic regression with patient-grouped 5-fold cross-validation was triangulated with LASSO and random forest. Dose-response across plaque grades was assessed with the Cochran-Armitage trend test, and circulation-specific associations were compared in models adjusted for age and sex (inter-reader Cohen's kappa = 0.93). Results: PISE was detected in 609/811 patients (75.1%); detection rose from 50.0% (<40 years) to 81.7% (>70 years; trend p = 5.6 x 10^-6). The strongest univariate correlate was vulnerable intracranial plaque (OR=8.29, 95% CI 5.54-12.40). Detection increased across plaque grades 0/1/2 (38.7% -> 77.2% -> 90.3%; Z=11.09). Anterior-circulation plaque showed a stronger association than posterior-circulation plaque (OR=4.42 vs 2.76). Vulnerable plaque (OR=2.37), plaque grade (OR=2.84 per grade), age (OR=1.38 per SD), and inpatient status (OR=3.18) remained independently associated (patient-grouped cross-validated AUC=0.755). Moyamoya disease was inversely associated (OR=0.25). Findings were consistent across imputation and all-examination sensitivity analyses. Conclusions: PISE is a frequently detected novel dural enhancement sign whose independent, graded, anatomically concordant association with intracranial atherosclerotic burden supports an atherosclerosis-related dural mechanism and warrants prospective validation.
ER  -